Historique de carrière de Henrich R. K. Guntermann
Anciens postes connus de Henrich R. K. Guntermann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/03/2016 | 29/09/2016 |
| Corporate Officer/Principal | 01/03/2016 | 11/07/2016 | |
| NUVO PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 21/09/2004 | 01/03/2016 |
| Corporate Officer/Principal | 16/12/2009 | 01/03/2016 | |
| President | 21/09/2004 | 16/12/2009 |
Formation de Henrich R. K. Guntermann
| Philipps University of Marburg | Doctorate Degree |
Statistiques
Internationale
| Canada | 3 |
| Allemagne | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| President | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
- Bourse
- Insiders
- Henrich R. K. Guntermann
- Expérience
